Isonics Corporation (ISON) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, Isonics Corporation (ISON) es una empresa del sector Industrials valorada en 0. Calificado con 38/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 15 mar 2026Perfil de Operaciones Industriales de Isonics Corporation (ISON)
Isonics Corporation serves the Homeland Security, Semiconductor, and Life Sciences industries, offering security services, wafer reclamation, and isotopes. The company focuses on developing solutions for asset protection, providing high-quality wafer services, and supplying isotopes for cancer imaging and treatment, positioning itself as a diversified industrial player.
Tesis de Inversión
Isonics Corporation operates in diverse sectors, including Homeland Security, Semiconductor, and Life Sciences. Key value drivers include the growing demand for security services, the increasing need for wafer reclamation in the semiconductor industry, and the expanding use of isotopes in healthcare. Growth catalysts involve strategic partnerships and expansion of service offerings within each division. Potential risks include market volatility, competition, and regulatory changes affecting the security, semiconductor, and healthcare industries. Investors should monitor the company's ability to innovate, secure contracts, and maintain regulatory compliance to assess its long-term growth potential.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Operates in three divisions: Homeland Security and Defense, Semiconductor, and Life Sciences.
- Offers security services for businesses and institutions in healthcare, education, retail, manufacturing, banking, and art industries.
- Specializes in high-quality wafer reclaim, test wafer production, wafer thinning, and custom wafer services with a focus on the 300mm market.
- Markets and sells isotopes to the healthcare industry for the imaging and treatment of cancer.
- Founded in 1992 and based in Golden, Colorado.
Fortalezas
- Diversified business model across multiple sectors.
- Expertise in security services, wafer processing, and isotope technology.
- Focus on high-quality wafer reclaim and custom wafer services.
- Established presence in the Homeland Security, Semiconductor, and Life Sciences markets.
Debilidades
- Small market capitalization.
- Limited financial resources compared to larger competitors.
- Dependence on specific contracts and projects for revenue generation.
- Potential vulnerability to market volatility and economic downturns.
Catalizadores
- Upcoming: Expansion of security service offerings to address growing demand for asset protection.
- Upcoming: Development of new isotope products for healthcare applications.
- Ongoing: Strategic partnerships to enhance capabilities and market reach.
- Ongoing: Increasing wafer reclamation services in the semiconductor industry.
- Ongoing: Focus on high-quality wafer reclaim and custom wafer services for the 300mm market.
Riesgos
- Potential: Competition from larger and more established companies in the security, semiconductor, and healthcare sectors.
- Potential: Regulatory changes affecting the security, semiconductor, and healthcare industries.
- Ongoing: Economic downturns impacting demand for security services and semiconductor products.
- Ongoing: Technological advancements rendering existing products and services obsolete.
- Potential: Limited financial resources compared to larger competitors.
Oportunidades de crecimiento
- Growth opportunity 1: Expanding Homeland Security Services: The increasing demand for security solutions in various sectors, including healthcare and education, presents a significant growth opportunity for Isonics. By developing advanced security technologies and expanding its service offerings, Isonics can capitalize on the growing market for asset protection and risk management. This expansion could lead to increased revenue and market share in the security services industry.
- Growth opportunity 2: Semiconductor Wafer Reclamation: The semiconductor industry's focus on cost reduction and environmental sustainability drives the demand for wafer reclamation services. Isonics can leverage its expertise in wafer thinning and custom wafer services to expand its market share in the 300mm wafer market. This growth opportunity involves investing in advanced equipment and technologies to enhance wafer reclamation capabilities.
- Growth opportunity 3: Life Sciences Isotope Sales: The increasing use of isotopes in cancer imaging and treatment presents a growth opportunity for Isonics in the Life Sciences sector. By expanding its isotope product line and distribution network, Isonics can increase its sales to healthcare providers and research institutions. This growth opportunity requires regulatory compliance and strategic partnerships with healthcare organizations.
- Growth opportunity 4: Strategic Partnerships: Forming strategic alliances with technology providers and industry leaders can enhance Isonics' capabilities and market reach. Collaborations with security technology companies, semiconductor manufacturers, and healthcare organizations can drive innovation and expand the company's service offerings. These partnerships can lead to new revenue streams and competitive advantages.
- Growth opportunity 5: Geographic Expansion: Expanding its operations to new geographic markets can drive growth for Isonics. By targeting regions with high demand for security services, semiconductor manufacturing, and healthcare solutions, Isonics can increase its customer base and revenue. This expansion requires market research, regulatory compliance, and strategic investments in infrastructure and personnel.
Oportunidades
- Expanding security service offerings to address growing demand.
- Increasing wafer reclamation services in the semiconductor industry.
- Developing new isotope products for healthcare applications.
- Forming strategic partnerships to enhance capabilities and market reach.
Amenazas
- Competition from larger and more established companies.
- Regulatory changes affecting the security, semiconductor, and healthcare industries.
- Economic downturns impacting demand for security services and semiconductor products.
- Technological advancements rendering existing products and services obsolete.
Ventajas competitivas
- Established expertise in security services, wafer processing, and isotope technology.
- Diversified business model across Homeland Security, Semiconductor, and Life Sciences sectors.
- Focus on high-quality wafer reclaim and custom wafer services for the 300mm market.
Acerca de ISON
Founded in 1992 and based in Golden, Colorado, Isonics Corporation (formerly A&R Materials, Inc.) operates across three divisions: Homeland Security and Defense, Semiconductor, and Life Sciences. The Homeland Security and Defense division develops solutions to protect and secure assets for clients, offering security services to businesses and institutions in healthcare, education, retail, manufacturing, banking, and art industries. The Semiconductor division specializes in wafer reclaim, test wafer production, wafer thinning, and custom wafer services, focusing on the 300mm market. The Life Sciences division markets and sells isotopes to the healthcare industry for cancer imaging and treatment. Isonics aims to provide comprehensive solutions across these sectors, leveraging its expertise in security, semiconductor services, and isotope technology. The company's evolution reflects a diversification strategy to address various industrial and healthcare needs.
Qué hacen
- Offers homeland security products and services to protect assets and resources.
- Provides security services for businesses and institutions in various industries.
- Specializes in high-quality wafer reclaim and test wafer production.
- Offers wafer thinning and custom wafer services for the semiconductor industry.
- Markets and sells isotopes to the healthcare industry for cancer imaging and treatment.
- Focuses on the 300mm wafer market within the semiconductor division.
Modelo de Negocio
- Generates revenue through security service contracts with businesses and institutions.
- Earns income from wafer reclaim, thinning, and custom services provided to semiconductor manufacturers.
- Sells isotopes to healthcare providers and research institutions for medical applications.
Contexto de la Industria
Isonics Corporation operates within the Specialty Business Services industry, serving the Homeland Security, Semiconductor, and Life Sciences sectors. The security services market is driven by increasing threats and the need for asset protection. The semiconductor industry relies on wafer reclamation to reduce costs and environmental impact. The healthcare sector utilizes isotopes for medical imaging and treatment. Isonics competes with companies offering similar services and products in each sector, requiring continuous innovation and strategic partnerships to maintain a competitive edge.
Clientes Clave
- Businesses and institutions in healthcare, education, retail, manufacturing, banking, and art industries.
- Semiconductor manufacturers requiring wafer reclaim and custom wafer services.
- Healthcare providers and research institutions using isotopes for cancer imaging and treatment.
Finanzas
Gráfico e información
Precio de la acción de Isonics Corporation (ISON): Price data unavailable
Últimas noticias
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para ISON.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para ISON.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de ISON en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Clasificación
Industria Specialty Business ServicesLiderazgo: Christopher Toffales
CEO
Christopher Toffales serves as the CEO of Isonics Corporation, managing a team of 384 employees. Information regarding his detailed career history, education, and previous roles is not available. His leadership is crucial in guiding Isonics across its Homeland Security and Defense, Semiconductor, and Life Sciences divisions, focusing on strategic growth and operational efficiency.
Historial: Due to limited information on Christopher Toffales' specific achievements and strategic decisions at Isonics, a comprehensive track record cannot be established. Assessing his impact on key company milestones requires further data on his leadership during specific periods and projects.
Información del mercado OTC de ISON
The OTC Other tier represents the lowest tier of the OTC market, indicating that Isonics Corporation may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike NYSE or NASDAQ listings, OTC Other stocks often lack stringent listing requirements, resulting in increased risk for investors.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- Lower trading volume and liquidity.
- Wider bid-ask spreads.
- Potential for price manipulation and fraud.
- Higher risk of delisting or suspension of trading.
- Verify the availability and accuracy of financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Review the company's legal and regulatory compliance.
- Monitor trading volume and price volatility.
- Understand the risks associated with OTC investing.
- Consult with a financial advisor before investing.
- Established business operations in multiple sectors.
- Long operating history since 1992.
- Presence in the Homeland Security, Semiconductor, and Life Sciences markets.
- Focus on high-quality wafer reclaim and custom wafer services.
Acciones de Isonics Corporation: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar ISON?
Isonics Corporation (ISON) actualmente tiene una puntuación IA de 38/100, indicando puntuación baja. Fortaleza clave: Diversified business model across multiple sectors.. Riesgo principal a monitorear: Potential: Competition from larger and more established companies in the security, semiconductor, and healthcare sectors.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de ISON?
ISON actualmente puntúa 38/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de ISON?
Los precios de ISON se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre ISON?
La cobertura de analistas para ISON incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en ISON?
Las categorías de riesgo para ISON incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Competition from larger and more established companies in the security, semiconductor, and healthcare sectors.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de ISON?
La relación P/E para ISON compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está ISON sobrevalorada o infravalorada?
Determinar si Isonics Corporation (ISON) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de ISON?
Isonics Corporation (ISON) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited information available on CEO track record and analyst coverage.
- OTC market investments carry higher risks due to lower liquidity and disclosure requirements.